Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENGAGE-PD
NCT05022147Phase 1Active, not recruiting
- Start
- Oct 2021
- Primary completion
- Nov 2024
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in Parkinson's disease (PD) and gait disorder. Primary endpoints: Stride Time Coefficient of Variation, Percentage of Time with Tremor Present and 1 more. Started Oct 2021; status: active, not recruiting.
02
Conditions
Parkinson's disease (PD)gait disorder
Beyond the preview
Go deeper on NCT05022147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05022147.